{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:29:13Z","timestamp":1791919753768,"version":"4.3.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Inorg Chem"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00775-019-01711-z","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T16:47:10Z","timestamp":1567788430000},"page":"1269-1278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metal coordination and peripheral substitution modulate the activity of cyclic tetrapyrroles on \u03b1S aggregation: a structural and cell-based study"],"prefix":"10.1007","volume":"24","author":[{"given":"Nazareno","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo A.","family":"Garro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Delgado-Oca\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla F.","family":"Ramunno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiamma A.","family":"Buratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Griesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio O.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"key":"1711_CR1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nn.2584","volume":"13","author":"S Gandhi","year":"2010","unstructured":"Gandhi S, Wood NW (2010) Genome-wide association studies: the key to unlocking neurodegeneration? Nat Neurosci 13:789\u2013794. \nhttps:\/\/doi.org\/10.1038\/nn.2584","journal-title":"Nat Neurosci"},{"key":"1711_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LML de Lau","year":"2006","unstructured":"de Lau LML, Breteler MMB (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5:525\u2013535. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"key":"1711_CR3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ncpneuro0924","volume":"4","author":"C Henchcliffe","year":"2008","unstructured":"Henchcliffe C, Beal MF (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4:600\u2013609. \nhttps:\/\/doi.org\/10.1038\/ncpneuro0924","journal-title":"Nat Clin Pract Neurol"},{"key":"1711_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R et al (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Lett 251:205\u2013208. \nhttps:\/\/doi.org\/10.1016\/S0304-3940(98)00504-7","journal-title":"Neurosci Lett"},{"key":"1711_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1159\/000107702","volume":"4","author":"S Papapetropoulos","year":"2007","unstructured":"Papapetropoulos S, Adi N, Ellul J et al (2007) A prospective study of familial versus sporadic Parkinson\u2019s disease. Neurodegener Dis 4:424\u2013427. \nhttps:\/\/doi.org\/10.1159\/000107702","journal-title":"Neurodegener Dis"},{"key":"1711_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1172\/JCI17575","volume":"111","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL (2003) Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Invest 111:145\u2013151. \nhttps:\/\/doi.org\/10.1172\/JCI17575","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"1711_CR7","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/S1353-8020(13)70017-8","volume":"20","author":"H McCann","year":"2014","unstructured":"McCann H, Stevens CH, Cartwright H, Halliday GM (2014) \u03b1-Synucleinopathy phenotypes. Parkinsonism Relat Disord 20(Suppl 1):S62\u2013S67. \nhttps:\/\/doi.org\/10.1016\/S1353-8020(13)70017-8","journal-title":"Parkinsonism Relat Disord"},{"key":"1711_CR8","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R et al (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95:6469\u20136473. \nhttps:\/\/doi.org\/10.1073\/pnas.95.11.6469","journal-title":"Proc Natl Acad Sci USA"},{"key":"1711_CR9","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1021\/bi030086j","volume":"42","author":"MJ Volles","year":"2003","unstructured":"Volles MJ, Lansbury PT (2003) Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson\u2019s disease. Biochemistry 42:7871\u20137878. \nhttps:\/\/doi.org\/10.1021\/bi030086j","journal-title":"Biochemistry"},{"key":"1711_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.expneurol.2007.05.022","volume":"209","author":"MR Cookson","year":"2008","unstructured":"Cookson MR, van der Brug M (2008) Cell systems and the toxic mechanism(s) of alpha-synuclein. Exp Neurol 209:5\u201311. \nhttps:\/\/doi.org\/10.1016\/j.expneurol.2007.05.022","journal-title":"Exp Neurol"},{"key":"1711_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00109-013-1038-9","volume":"91","author":"SE Eisbach","year":"2013","unstructured":"Eisbach SE, Outeiro TF (2013) Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson\u2019s disease pathology. J Mol Med 91:693\u2013703. \nhttps:\/\/doi.org\/10.1007\/s00109-013-1038-9","journal-title":"J Mol Med"},{"key":"1711_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/biom5020282","volume":"5","author":"HL Roberts","year":"2015","unstructured":"Roberts HL, Brown DR (2015) Seeking a mechanism for the toxicity of oligomeric \u03b1-synuclein. Biomolecules 5:282\u2013305. \nhttps:\/\/doi.org\/10.3390\/biom5020282","journal-title":"Biomolecules"},{"key":"1711_CR13","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK et al (2011) In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci USA 108:4194\u20134199. \nhttps:\/\/doi.org\/10.1073\/pnas.1100976108","journal-title":"Proc Natl Acad Sci USA"},{"key":"1711_CR14","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/emboj.2009.257","volume":"28","author":"DP Karpinar","year":"2009","unstructured":"Karpinar DP, Balija MBG, K\u00fcgler S et al (2009) Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson\u2019s disease models. EMBO J 28:3256\u20133268. \nhttps:\/\/doi.org\/10.1038\/emboj.2009.257","journal-title":"EMBO J"},{"key":"1711_CR15","doi-asserted-by":"publisher","first-page":"e1004741","DOI":"10.1371\/journal.pgen.1004741","volume":"10","author":"DF L\u00e1zaro","year":"2014","unstructured":"L\u00e1zaro DF, Rodrigues EF, Langohr R et al (2014) Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation. PLoS Genet 10:e1004741. \nhttps:\/\/doi.org\/10.1371\/journal.pgen.1004741","journal-title":"PLoS Genet"},{"key":"1711_CR16","doi-asserted-by":"publisher","first-page":"e0184117","DOI":"10.1371\/journal.pone.0184117","volume":"12","author":"M Pokrzywa","year":"2017","unstructured":"Pokrzywa M, Pawe\u0142ek K, Kucia WE et al (2017) Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson\u2019s disease. PLoS One 12:e0184117. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0184117","journal-title":"PLoS One"},{"key":"1711_CR17","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.chembiol.2018.08.005","volume":"25","author":"M Kurnik","year":"2018","unstructured":"Kurnik M, Sahin C, Andersen CB et al (2018) Potent \u03b1-synuclein aggregation inhibitors, identified by high-throughput screening, mainly target the monomeric state. Cell Chem Biol 25:1389\u20131402.e9. \nhttps:\/\/doi.org\/10.1016\/j.chembiol.2018.08.005","journal-title":"Cell Chem Biol"},{"key":"1711_CR18","doi-asserted-by":"publisher","first-page":"4518060","DOI":"10.1155\/2018\/4518060","volume":"2018","author":"C Tonda-Turo","year":"2018","unstructured":"Tonda-Turo C, Herva M, Chiono V et al (2018) Influence of drug-carrier polymers on alpha-synucleinopathies: a neglected aspect in new therapies development. Biomed Res Int 2018:4518060. \nhttps:\/\/doi.org\/10.1155\/2018\/4518060","journal-title":"Biomed Res Int"},{"key":"1711_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/17460441.2018.1428556","volume":"13","author":"I Trigo-Damas","year":"2018","unstructured":"Trigo-Damas I, Del Rey NL-G, Blesa J (2018) Novel models for Parkinson\u2019s disease and their impact on future drug discovery. Expert Opin Drug Discov 13:229\u2013239. \nhttps:\/\/doi.org\/10.1080\/17460441.2018.1428556","journal-title":"Expert Opin Drug Discov"},{"key":"1711_CR20","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804\u20132815","journal-title":"J Neurosci"},{"key":"1711_CR21","doi-asserted-by":"publisher","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","volume":"111","author":"J Burr\u00e9","year":"2014","unstructured":"Burr\u00e9 J, Sharma M, S\u00fcdhof TC (2014) \u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc Natl Acad Sci USA 111:E4274\u2013E4283. \nhttps:\/\/doi.org\/10.1073\/pnas.1416598111","journal-title":"Proc Natl Acad Sci USA"},{"key":"1711_CR22","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009399. \nhttps:\/\/doi.org\/10.1101\/cshperspect.a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1711_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1096\/fj.03-1112rev","volume":"18","author":"A Sidhu","year":"2004","unstructured":"Sidhu A, Wersinger C, Vernier P (2004) Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J 18:637\u2013647. \nhttps:\/\/doi.org\/10.1096\/fj.03-1112rev","journal-title":"FASEB J"},{"key":"1711_CR24","doi-asserted-by":"publisher","first-page":"11165","DOI":"10.1523\/JNEUROSCI.2559-04.2004","volume":"24","author":"L Yavich","year":"2004","unstructured":"Yavich L, Tanila H, Veps\u00e4l\u00e4inen S, J\u00e4k\u00e4l\u00e4 P (2004) Role of alpha-synuclein in presynaptic dopamine recruitment. J Neurosci 24:11165\u201311170. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.2559-04.2004","journal-title":"J Neurosci"},{"key":"1711_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","volume":"1822","author":"L Breydo","year":"2012","unstructured":"Breydo L, Wu JW, Uversky VN (2012) \u0391-synuclein misfolding and Parkinson\u2019s disease. Biochim Biophys Acta 1822:261\u2013285. \nhttps:\/\/doi.org\/10.1016\/j.bbadis.2011.10.002","journal-title":"Biochim Biophys Acta"},{"key":"1711_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1021\/ja044834j","volume":"127","author":"MM Dedmon","year":"2005","unstructured":"Dedmon MM, Lindorff-Larsen K, Christodoulou J et al (2005) Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J Am Chem Soc 127:476\u2013477. \nhttps:\/\/doi.org\/10.1021\/ja044834j","journal-title":"J Am Chem Soc"},{"key":"1711_CR27","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1073\/pnas.0407146102","volume":"102","author":"CW Bertoncini","year":"2005","unstructured":"Bertoncini CW, Jung Y-S, Fernandez CO et al (2005) Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc Natl Acad Sci USA 102:1430\u20131435. \nhttps:\/\/doi.org\/10.1073\/pnas.0407146102","journal-title":"Proc Natl Acad Sci USA"},{"key":"1711_CR28","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/pro.194","volume":"18","author":"M-K Cho","year":"2009","unstructured":"Cho M-K, Nodet G, Kim H-Y et al (2009) Structural characterization of alpha-synuclein in an aggregation prone state. Protein Sci 18:1840\u20131846. \nhttps:\/\/doi.org\/10.1002\/pro.194","journal-title":"Protein Sci"},{"key":"1711_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti F, Dobson CM (2017) Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem 86:27\u201368. \nhttps:\/\/doi.org\/10.1146\/annurev-biochem-061516-045115","journal-title":"Annu Rev Biochem"},{"key":"1711_CR30","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.febslet.2013.02.049","volume":"587","author":"GM Moriarty","year":"2013","unstructured":"Moriarty GM, Janowska MK, Kang L, Baum J (2013) Exploring the accessible conformations of N-terminal acetylated \u03b1-synuclein. FEBS Lett 587:1128\u20131138. \nhttps:\/\/doi.org\/10.1016\/j.febslet.2013.02.049","journal-title":"FEBS Lett"},{"key":"1711_CR31","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/pro.2088","volume":"21","author":"L Kang","year":"2012","unstructured":"Kang L, Moriarty GM, Woods LA et al (2012) N-terminal acetylation of \u03b1-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer. Protein Sci 21:911\u2013917. \nhttps:\/\/doi.org\/10.1002\/pro.2088","journal-title":"Protein Sci"},{"key":"1711_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/cmdc.201100585","volume":"7","author":"T Liu","year":"2012","unstructured":"Liu T, Bitan G (2012) Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms. ChemMedChem 7:359\u2013374. \nhttps:\/\/doi.org\/10.1002\/cmdc.201100585","journal-title":"ChemMedChem"},{"key":"1711_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.semnuclmed.2016.09.006","volume":"47","author":"VL Villemagne","year":"2017","unstructured":"Villemagne VL, Dor\u00e9 V, Bourgeat P et al (2017) A\u03b2-amyloid and Tau Imaging in Dementia. Semin Nucl Med 47:75\u201388. \nhttps:\/\/doi.org\/10.1053\/j.semnuclmed.2016.09.006","journal-title":"Semin Nucl Med"},{"key":"1711_CR34","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/marc.201200817","volume":"34","author":"K Arja","year":"2013","unstructured":"Arja K, Sj\u00f6lander D, \u00c5slund A et al (2013) Enhanced fluorescent assignment of protein aggregates by an oligothiophene-porphyrin-based amyloid ligand. Macromol Rapid Commun 34:723\u2013730. \nhttps:\/\/doi.org\/10.1002\/marc.201200817","journal-title":"Macromol Rapid Commun"},{"key":"1711_CR35","doi-asserted-by":"publisher","first-page":"21057","DOI":"10.1073\/pnas.0902603106","volume":"106","author":"GR Lamberto","year":"2009","unstructured":"Lamberto GR, Binolfi A, Orcellet ML et al (2009) Structural and mechanistic basis behind the inhibitory interaction of PcTS on alpha-synuclein amyloid fibril formation. Proc Natl Acad Sci USA 106:21057\u201321062. \nhttps:\/\/doi.org\/10.1073\/pnas.0902603106","journal-title":"Proc Natl Acad Sci USA"},{"key":"1711_CR36","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.bpj.2018.01.003","volume":"114","author":"AA Valiente-Gabioud","year":"2018","unstructured":"Valiente-Gabioud AA, Riedel D, Outeiro TF et al (2018) Binding modes of phthalocyanines to amyloid \u03b2 peptide and their effects on amyloid fibril formation. Biophys J 114:1036\u20131045. \nhttps:\/\/doi.org\/10.1016\/j.bpj.2018.01.003","journal-title":"Biophys J"},{"key":"1711_CR37","doi-asserted-by":"publisher","first-page":"32036","DOI":"10.1074\/jbc.M111.242958","volume":"286","author":"GR Lamberto","year":"2011","unstructured":"Lamberto GR, Torres-Monserrat V, Bertoncini CW et al (2011) Toward the discovery of effective polycyclic inhibitors of alpha-synuclein amyloid assembly. J Biol Chem 286:32036\u201332044. \nhttps:\/\/doi.org\/10.1074\/jbc.M111.242958","journal-title":"J Biol Chem"},{"key":"1711_CR38","doi-asserted-by":"publisher","first-page":"9215","DOI":"10.1002\/anie.200704051","volume":"46","author":"B Bulic","year":"2007","unstructured":"Bulic B, Pickhardt M, Khlistunova I et al (2007) Rhodanine-based tau aggregation inhibitors in cell models of tauopathy. Angew Chem Int Ed Engl 46:9215\u20139219. \nhttps:\/\/doi.org\/10.1002\/anie.200704051","journal-title":"Angew Chem Int Ed Engl"},{"key":"1711_CR39","doi-asserted-by":"publisher","first-page":"a006387","DOI":"10.1101\/cshperspect.a006387","volume":"2","author":"D Schenk","year":"2012","unstructured":"Schenk D, Basi GS, Pangalos MN (2012) Treatment strategies targeting amyloid \u03b2-protein. Cold Spring Harb Perspect Med 2:a006387. \nhttps:\/\/doi.org\/10.1101\/cshperspect.a006387","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1711_CR40","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1021\/bi0600749","volume":"45","author":"M Masuda","year":"2006","unstructured":"Masuda M, Suzuki N, Taniguchi S et al (2006) Small molecule inhibitors of alpha-synuclein filament assembly. Biochemistry 45:6085\u20136094. \nhttps:\/\/doi.org\/10.1021\/bi0600749","journal-title":"Biochemistry"},{"key":"1711_CR41","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1021\/ar050068p","volume":"39","author":"B Caughey","year":"2006","unstructured":"Caughey B, Caughey WS, Kocisko DA et al (2006) Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: a common mechanism for anti-TSE compounds? Acc Chem Res 39:646\u2013653. \nhttps:\/\/doi.org\/10.1021\/ar050068p","journal-title":"Acc Chem Res"},{"key":"1711_CR42","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nsmb.1437","volume":"15","author":"DE Ehrnhoefer","year":"2008","unstructured":"Ehrnhoefer DE, Bieschke J, Boeddrich A et al (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15:558\u2013566. \nhttps:\/\/doi.org\/10.1038\/nsmb.1437","journal-title":"Nat Struct Mol Biol"},{"key":"1711_CR43","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1128\/AAC.01599-06","volume":"51","author":"WS Caughey","year":"2007","unstructured":"Caughey WS, Priola SA, Kocisko DA et al (2007) Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activity. Antimicrob Agents Chemother 51:3887\u20133894. \nhttps:\/\/doi.org\/10.1128\/AAC.01599-06","journal-title":"Antimicrob Agents Chemother"},{"key":"1711_CR44","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","volume":"125","author":"J Wagner","year":"2013","unstructured":"Wagner J, Ryazanov S, Leonov A et al (2013) Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease. Acta Neuropathol 125:795\u2013813. \nhttps:\/\/doi.org\/10.1007\/s00401-013-1114-9","journal-title":"Acta Neuropathol"},{"key":"1711_CR45","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00401-014-1265-3","volume":"127","author":"J Levin","year":"2014","unstructured":"Levin J, Schmidt F, Boehm C et al (2014) The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset. Acta Neuropathol 127:779\u2013780. \nhttps:\/\/doi.org\/10.1007\/s00401-014-1265-3","journal-title":"Acta Neuropathol"},{"key":"1711_CR46","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/prot.24080","volume":"80","author":"R Scherzer-Attali","year":"2012","unstructured":"Scherzer-Attali R, Shaltiel-Karyo R, Adalist YH et al (2012) Generic inhibition of amyloidogenic proteins by two naphthoquinone-tryptophan hybrid molecules. Proteins 80:1962\u20131973. \nhttps:\/\/doi.org\/10.1002\/prot.24080","journal-title":"Proteins"},{"key":"1711_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/13506129.2011.582902","volume":"18","author":"A Frydman-Marom","year":"2011","unstructured":"Frydman-Marom A, Shaltiel-Karyo R, Moshe S, Gazit E (2011) The generic amyloid formation inhibition effect of a designed small aromatic \u03b2-breaking peptide. Amyloid 18:119\u2013127. \nhttps:\/\/doi.org\/10.3109\/13506129.2011.582902","journal-title":"Amyloid"},{"key":"1711_CR48","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/anie.200802123","volume":"48","author":"A Frydman-Marom","year":"2009","unstructured":"Frydman-Marom A, Rechter M, Shefler I et al (2009) Cognitive-performance recovery of Alzheimer\u2019s disease model mice by modulation of early soluble amyloidal assemblies. Angew Chem Int Ed Engl 48:1981\u20131986. \nhttps:\/\/doi.org\/10.1002\/anie.200802123","journal-title":"Angew Chem Int Ed Engl"},{"key":"1711_CR49","doi-asserted-by":"publisher","first-page":"41755","DOI":"10.1038\/srep41755","volume":"7","author":"F Gonz\u00e1lez-Liz\u00e1rraga","year":"2017","unstructured":"Gonz\u00e1lez-Liz\u00e1rraga F, Soc\u00edas SB, \u00c1vila CL et al (2017) Repurposing doxycycline for synucleinopathies: remodelling of \u03b1-synuclein oligomers towards non-toxic parallel beta-sheet structured species. Sci Rep 7:41755. \nhttps:\/\/doi.org\/10.1038\/srep41755","journal-title":"Sci Rep"},{"key":"1711_CR50","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.1073\/pnas.1804198115","volume":"115","author":"J Pujols","year":"2018","unstructured":"Pujols J, Pe\u00f1a-D\u00edaz S, L\u00e1zaro DF et al (2018) Small molecule inhibits \u03b1-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proc Natl Acad Sci USA 115:10481\u201310486. \nhttps:\/\/doi.org\/10.1073\/pnas.1804198115","journal-title":"Proc Natl Acad Sci USA"},{"key":"1711_CR51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mcn.2018.04.006","volume":"89","author":"D Valdinocci","year":"2018","unstructured":"Valdinocci D, Grant GD, Dickson TC, Pountney DL (2018) Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates. Mol Cell Neurosci 89:80\u201394. \nhttps:\/\/doi.org\/10.1016\/j.mcn.2018.04.006","journal-title":"Mol Cell Neurosci"},{"key":"1711_CR52","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3389\/fnmol.2017.00447","volume":"10","author":"K Schwab","year":"2017","unstructured":"Schwab K, Frahm S, Horsley D et al (2017) A protein aggregation inhibitor, leuco-methylthioninium bis(hydromethanesulfonate), decreases \u03b1-synuclein inclusions in a transgenic mouse model of synucleinopathy. Front Mol Neurosci 10:447. \nhttps:\/\/doi.org\/10.3389\/fnmol.2017.00447","journal-title":"Front Mol Neurosci"},{"key":"1711_CR53","doi-asserted-by":"publisher","first-page":"8337","DOI":"10.1038\/s41598-018-26645-5","volume":"8","author":"L Palazzi","year":"2018","unstructured":"Palazzi L, Bruzzone E, Bisello G et al (2018) Oleuropein aglycone stabilizes the monomeric \u03b1-synuclein and favours the growth of non-toxic aggregates. Sci Rep 8:8337. \nhttps:\/\/doi.org\/10.1038\/s41598-018-26645-5","journal-title":"Sci Rep"},{"key":"1711_CR54","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1021\/acschemneuro.7b00261","volume":"8","author":"NN Jha","year":"2017","unstructured":"Jha NN, Kumar R, Panigrahi R et al (2017) Comparison of \u03b1-synuclein fibril inhibition by four different amyloid inhibitors. ACS Chem Neurosci 8:2722\u20132733. \nhttps:\/\/doi.org\/10.1021\/acschemneuro.7b00261","journal-title":"ACS Chem Neurosci"},{"key":"1711_CR55","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.bbagen.2017.12.007","volume":"1862","author":"AM Reiner","year":"2018","unstructured":"Reiner AM, Schmidt F, Ryazanov S et al (2018) Photophysics of diphenyl-pyrazole compounds in solutions and \u03b1-synuclein aggregates. Biochim Biophys Acta Gen Subj 1862:800\u2013807. \nhttps:\/\/doi.org\/10.1016\/j.bbagen.2017.12.007","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"1711_CR56","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1021\/acs.accounts.5b00507","volume":"49","author":"AA Valiente-Gabioud","year":"2016","unstructured":"Valiente-Gabioud AA, Miotto MC, Chesta ME et al (2016) Phthalocyanines as molecular scaffolds to block disease-associated protein aggregation. Acc Chem Res 49:801\u2013808. \nhttps:\/\/doi.org\/10.1021\/acs.accounts.5b00507","journal-title":"Acc Chem Res"},{"key":"1711_CR57","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.1038\/ncomms6857","volume":"5","author":"L Fonseca-Ornelas","year":"2014","unstructured":"Fonseca-Ornelas L, Eisbach SE, Paulat M et al (2014) Small molecule-mediated stabilization of vesicle-associated helical \u03b1-synuclein inhibits pathogenic misfolding and aggregation. Nat Commun 5:5857. \nhttps:\/\/doi.org\/10.1038\/ncomms6857","journal-title":"Nat Commun"},{"key":"1711_CR58","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1021\/ja312471h","volume":"135","author":"E Akoury","year":"2013","unstructured":"Akoury E, Gajda M, Pickhardt M et al (2013) Inhibition of tau filament formation by conformational modulation. J Am Chem Soc 135:2853\u20132862. \nhttps:\/\/doi.org\/10.1021\/ja312471h","journal-title":"J Am Chem Soc"},{"key":"1711_CR59","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1021\/acschemneuro.8b00436","volume":"10","author":"R Chakraborty","year":"2019","unstructured":"Chakraborty R, Sahoo S, Halder N et al (2019) Conformational-switch based strategy triggered by [18] \u03c0 heteroannulenes toward reduction of alpha synuclein oligomer toxicity. ACS Chem Neurosci 10:573\u2013587. \nhttps:\/\/doi.org\/10.1021\/acschemneuro.8b00436","journal-title":"ACS Chem Neurosci"},{"key":"1711_CR60","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B Caughey","year":"2003","unstructured":"Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267\u2013298. \nhttps:\/\/doi.org\/10.1146\/annurev.neuro.26.010302.081142","journal-title":"Annu Rev Neurosci"},{"key":"1711_CR61","doi-asserted-by":"publisher","first-page":"12117","DOI":"10.1073\/pnas.95.21.12117","volume":"95","author":"WS Caughey","year":"1998","unstructured":"Caughey WS, Raymond LD, Horiuchi M, Caughey B (1998) Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc Natl Acad Sci USA 95:12117\u201312122. \nhttps:\/\/doi.org\/10.1073\/pnas.95.21.12117","journal-title":"Proc Natl Acad Sci USA"},{"key":"1711_CR62","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.287.5457.1503","volume":"287","author":"SA Priola","year":"2000","unstructured":"Priola SA, Raines A, Caughey WS (2000) Porphyrin and phthalocyanine antiscrapie compounds. Science 287:1503\u20131506","journal-title":"Science"},{"key":"1711_CR63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-62703-305-3_15","volume":"981","author":"M Johnson","year":"2013","unstructured":"Johnson M, Geeves MA, Mulvihill DP (2013) Production of amino-terminally acetylated recombinant proteins in E. coli. Methods Mol Biol 981:193\u2013200. \nhttps:\/\/doi.org\/10.1007\/978-1-62703-305-3_15","journal-title":"Methods Mol Biol"},{"key":"1711_CR64","doi-asserted-by":"publisher","first-page":"16233","DOI":"10.1021\/bi048453u","volume":"43","author":"W Hoyer","year":"2004","unstructured":"Hoyer W, Cherny D, Subramaniam V, Jovin TM (2004) Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. Biochemistry 43:16233\u201316242. \nhttps:\/\/doi.org\/10.1021\/bi048453u","journal-title":"Biochemistry"},{"key":"1711_CR65","unstructured":"Cavanagh J, Fairbrother W, Palmer A III, Skelton N (1995) Protein NMR spectroscopy: principles and practice. Academic Press. ISBN: 9780080515298"},{"key":"1711_CR66","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jinorgbio.2012.06.011","volume":"117","author":"AA Valiente-Gabioud","year":"2012","unstructured":"Valiente-Gabioud AA, Torres-Monserrat V, Molina-Rubino L et al (2012) Structural basis behind the interaction of Zn2+ with the protein \u03b1-synuclein and the A\u03b2 peptide: a comparative analysis. J Inorg Biochem 117:334\u2013341. \nhttps:\/\/doi.org\/10.1016\/j.jinorgbio.2012.06.011","journal-title":"J Inorg Biochem"}],"container-title":["JBIC Journal of Biological Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-019-01711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00775-019-01711-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-019-01711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T23:26:57Z","timestamp":1599175617000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00775-019-01711-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1711"],"URL":"https:\/\/doi.org\/10.1007\/s00775-019-01711-z","relation":{},"ISSN":["0949-8257","1432-1327"],"issn-type":[{"value":"0949-8257","type":"print"},{"value":"1432-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]},"assertion":[{"value":"18 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}